In contrast, CAL-101 (50 mg kg−1) had negligible effects on inhibiting basal AKT signalling in EA PCa cell lines overexpressing PI3Kδ-S, as phosphorylation states of AKT and S6 were comparable to vehicle-treated cells (Fig. 5a). The gene discussed is AKT1; the disease is posterior cortical atrophy.